ArticleInvestigational new drugs2018

Successful treatment with an EGFR tyrosine kinase inhibitor Afatinib in a patient with combined small-cell lung Cancer with EGFR mutation.

Midori Tanaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.